Authors:
SYED N
MURPHY J
ZIMMERMAN T
MARK MH
SAGE JI
Citation: N. Syed et al., 10 YEARS EXPERIENCE WITH ENTERAL LEVODOPA INFUSIONS FOR MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE, Movement disorders, 13(2), 1998, pp. 336-338
Authors:
KIEBURTZ K
SHOULSON I
FAHN S
MCDERMOTT M
KOLLER W
LEWITT P
NUTT J
KURTH M
BREWER M
LEW M
WELSH M
WATERS C
BENNETT J
ROSTRUFFNER E
FEIGIN A
GARDINER I
KURLAN R
HAMMERSTAD J
STONE C
JANKOVIC J
BEACH J
TETRUD J
KELKER K
STANDAERT DG
GROWDON JH
TENNIS M
GRAEFE K
MARK MH
KELLY SJ
PAHWA R
MCGUIRE D
HUBBLE J
FACTOR SA
BROWN DL
TUITE P
SIME E
LANG DL
GREENE P
WINFIELD H
PAULSON G
ZOOG K
WEEKS C
SHULTS C
FONTAINE D
JUNCOS JL
WOOD C
SHANNON K
JAGLIN JA
TORNABENE J
LANNON MC
DAVIES R
FRIEDMAN J
TARIOT PN
HALL WJ
HERNDON R
PFEIFFER RF
PLUMB S
CASACELI C
RANDOLPH H
BEHMAN H
CONNORTON J
DAY D
RUDOLPH A
PELUSIO R
GUTHRIE B
CLAUDE K
ORME C
BAKER D
NOBEL R
IRVINE C
WATTS A
GORDIN A
HEIKKINEN H
RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
Authors:
PICCINI P
MORRISH PK
TURJANSKI N
SAWLE GV
BURN DJ
WEEKS RA
MARK MH
MARAGANORE DM
LEES AJ
BROOKS DJ
Citation: P. Piccini et al., DOPAMINERGIC FUNCTION IN FAMILIAL PARKINSONS-DISEASE - A CLINICAL ANDF-18 DOPA POSITRON EMISSION TOMOGRAPHY STUDY, Annals of neurology, 41(2), 1997, pp. 222-229
Authors:
RICHARD IH
KURLAN R
TANNER C
FACTOR S
HUBBLE J
SUCHOWERSKY O
WATERS C
GOETZ C
JUNCOS JL
STERN M
HARRISON MB
SETHI KD
STANDAERT D
TROSCH R
REICH S
KIEBURTZ K
FEIGIN A
MARSHALL FJ
GAUTHIER S
PANISSET M
LEW ME
FRIEDMAN JH
PAULSON G
RODNITZKY RL
HAUSER R
KURTH M
HURTIG H
THAL L
ELMER LW
PERLMUTTER JS
GOLBE LI
COMELLA C
LANG A
MARK MH
SINGER C
SHOULSON I
WEINER WJ
PFEIFFER R
MAREK KL
NUTT J
WOOTEN GF
JANKOVIC J
LEWITT P
HOEHN M
BENNETT J
PARSA M
KOLLER W
Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077
Citation: Ml. Wagner et al., COMPLICATIONS OF DISEASE AND THERAPY - A COMPARISON OF YOUNGER AND OLDER PATIENTS WITH PARKINSONS-DISEASE, Annals of clinical and laboratory science, 26(5), 1996, pp. 389-395
Citation: Ma. Menza et al., PERSONALITY-CORRELATES OF [F-18] DOPA STRIATAL UPTAKE - RESULTS OF POSITRON-EMISSION TOMOGRAPHY IN PARKINSONS-DISEASE, The Journal of neuropsychiatry and clinical neurosciences, 7(2), 1995, pp. 176-179
Authors:
MARK MH
SAGE JI
WALTERS AS
DUVOISIN RC
MILLER DC
Citation: Mh. Mark et al., BINSWANGERS-DISEASE PRESENTING AS LEVODOPA-RESPONSIVE PARKINSONISM - CLINICOPATHOLOGICAL STUDY OF 3 CASES, Movement disorders, 10(4), 1995, pp. 450-454
Citation: Ji. Sage et Mh. Mark, DRENCHING SWEATS AS AN OFF PHENOMENON IN PARKINSONS-DISEASE - TREATMENT AND RELATION TO PLASMA LEVODOPA PROFILE, Annals of neurology, 37(1), 1995, pp. 120-122
Citation: Ma. Menza et Mh. Mark, PARKINSONS-DISEASE AND DEPRESSION - THE RELATIONSHIP TO DISABILITY AND PERSONALITY, The Journal of neuropsychiatry and clinical neurosciences, 6(2), 1994, pp. 165-169
Citation: Tr. Zimmerman et al., SEVERE EVENING DYSKINESIAS IN ADVANCED PARKINSONS-DISEASE - CLINICAL DESCRIPTION, RELATION TO PLASMA LEVODOPA, AND TREATMENT, Movement disorders, 9(2), 1994, pp. 173-177
Citation: Ji. Sage et Mh. Mark, DIAGNOSIS AND TREATMENT OF PARKINSONS-DISEASE IN THE ELDERLY, Journal of general internal medicine, 9(10), 1994, pp. 583-589
Citation: Mh. Mark et Ji. Sage, AN ANALYSIS OF TREATMENT OPTIONS AND OUTCOME IN PATIENTS WITH PARKINSONS-DISEASE AND SEVERE DYSKINESIAS, Annals of clinical and laboratory science, 24(1), 1994, pp. 12-21
Authors:
LAZZARINI AM
MYERS RH
ZIMMERMAN TR
MARK MH
GOLBE LI
SAGE JI
JOHNSON WG
DUVOISIN RC
Citation: Am. Lazzarini et al., A CLINICAL GENETIC-STUDY OF PARKINSONS-DISEASE - EVIDENCE FOR DOMINANT TRANSMISSION, Neurology, 44(3), 1994, pp. 499-506
Authors:
KIEBURTZ K
MCDERMOTT M
SHOULSON I
OAKES D
FAHN S
LANG A
PENNEY JB
RODNITZKY R
SHULTS C
TANNER C
TETRUD J
GORDON M
LEWITT P
BENNETT J
KOLLER W
FRIEDMAN JH
KURLAN R
OBRIEN C
MARK MH
WEINER WJ
SANCHEZRAMOS J
PAULSON G
COMELLA C
JANKOVIC J
OLANOW W
SHANNON K
LEWIS P
WINFIELD L
CIECIERSKI K
MISTURA K
LANDOW E
DIETRICH S
GEBHARDT AM
BARTER R
KENNEDY D
CULLEN KA
GARDINER IF
BERGEN M
PATTERSON V
FABRIELE M
SHELDON C
CORNELIUS L
DUDTE K
THELEN JA
DUNNE C
GAUGER L
MALAPIRA T
COURVILLE K
TROTTER H
PELUSIO RM
RUDOLPH A
CASACELI C
MILLER C
BOETTRICH C
CONNORTON J
BYRNE L
ORME C
BORDWELL K
MCMANUS J
SOTACK J
RANDOLPH H
KAVANAUGH B
BAKER D
RUMFOLA L
NOBEL R
EBERLY S
PLUMB S
WATTS A
GERWITZ K
DARCY S
EVANS P
FREDERICK D
DELLAPENA L
SINGLETARY V
TARIOT P
BELL E
GRIGGS RC
HALL WJ
HERNDON R
MARSDEN CD
CHASE TN
COHEN G
FLEISS J
JACOBS L
MOSS AJ
MELAMED E
DORFLINGER E
YOO K
SHIMOUN G
MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347